Empyrean Capital Partners, LP Bausch & Lomb Corp Transaction History
Empyrean Capital Partners, LP
- $1.81 Billion
- Q4 2024
A detailed history of Empyrean Capital Partners, LP transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Empyrean Capital Partners, LP holds 931,000 shares of BLCO stock, worth $15.1 Million. This represents 0.93% of its overall portfolio holdings.
Number of Shares
931,000
Previous 1,238,000
24.8%
Holding current value
$15.1 Million
Previous $23.9 Million
29.4%
% of portfolio
0.93%
Previous 1.19%
Shares
3 transactions
Others Institutions Holding BLCO
# of Institutions
127Shares Held
35.1MCall Options Held
256KPut Options Held
187K-
Icahn Carl C Sunny Isles Beach, FL3.5MShares$56.9 Million0.86% of portfolio
-
Maple Rock Capital Partners Inc. Toronto, A63.17MShares$51.5 Million1.8% of portfolio
-
Alberta Investment Management Corp Edmonton, A03.01MShares$48.9 Million0.41% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.88MShares$30.6 Million0.03% of portfolio
-
Goldentree Asset Management LP New York, NY1.73MShares$28.1 Million2.37% of portfolio
About Bausch & Lomb Corp
- Ticker BLCO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 350,000,000
- Market Cap $5.69B
- Description
- Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...